Reportable Segment Information (Tables)

6 Months Ended

Mar. 31, 2023

Segment Reporting [Abstract]

Summary of Financial Information for Each Reportable Segment

The following table presents various financial information for each reportable segment for the three and six months ended March 31, 2023 and 2022.

	Three months ended						Six months ended
	March 31						March 31
(In millions - unaudited)	2023			2022			2023			2022
SALES
Life Sciences	$	240		$	204		$	447		$	374
Personal Care		167			172			305			318
Specialty Additives		161			182			304			338
Intermediates		51			66			105			119
Intersegment sales (a)		(16	)		(20	)		(33	)		(34	)
	$	603		$	604		$	1,128		$	1,115
OPERATING INCOME (LOSS)
Life Sciences	$	58		$	43		$	92		$	64
Personal Care		14			28			25			42
Specialty Additives		15			26			16			44
Intermediates		17			27			37			42
Unallocated and other		(21	)		(24	)		(50	)		(50	)
	$	83		$	100		$	120		$	142
DEPRECIATION EXPENSE
Life Sciences	$	10		$	8		$	20		$	16
Personal Care		10			9			20			18
Specialty Additives		14			17			28			33
Intermediates		3			3			6			7
	$	37		$	37		$	74		$	74
AMORTIZATION EXPENSE
Life Sciences	$	7		$	7		$	14		$	14
Personal Care		11			12			22			24
Specialty Additives		5			5			9			9
Intermediates		—			—			1			—
	$	23		$	24		$	46		$	47
EBITDA (b)
Life Sciences	$	75		$	58		$	126		$	94
Personal Care		35			49			67			84
Specialty Additives		34			48			53			86
Intermediates		20			30			44			49
Unallocated and other		(21	)		(24	)		(50	)		(50	)
	$	143		$	161		$	240		$	263

	March 31		September 30
(In millions - unaudited)	2023		2022
TOTAL ASSETS
Life Sciences	$	1,964	$	1,905
Personal Care		1,079		1,073
Specialty Additives		1,664		1,567
Intermediates		172		170
Unallocated and other		1,304		1,498
	$	6,183	$	6,213

(a)Intersegment sales from Intermediates are accounted for at prices that approximate fair value. All other intersegment sales are accounted for at cost.

(b)Excludes income (loss) from discontinued operations and other net periodic benefit loss (income). See the Statement of Consolidated Comprehensive Income (Loss) for applicable amounts excluded.